FDA Warning Letter — Ampride
The FDA took a Warning Letter action against Ampride on Dec 22, 2016 (Grand Island, NE). The action was issued by CTP and concerns tobacco products.
Action Details
- Facility
- Ampride
- Date
- Dec 22, 2016
- Fiscal Year
- 2017
- Product Type
- Tobacco
- Center
- CTP
- Location
- Grand Island, NE (United States)